Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry
Results 1 - 20 out of 500 displayed.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 »
Reset ↻

Fractyl Health Announces Positive Initial Clinical Results Demonstrating Weight Maintenance Following GLP-1 Discontinuation and Revita Procedure in First Patient of the REVEAL-1 Cohort

Read more ››

By: GlobeNewswire - 13 Jan 2025

Related companies: Fractyl Health, Inc.

Akero Therapeutics Completes Enrollment of the Double-Blind Portion of the Phase 3 SYNCHRONY Real-World Study Evaluating Efruxifermin (EFX) in Patients with Non-Invasively Diagnosed MASH or MASLD

Read more ››

By: GlobeNewswire - 13 Jan 2025

Related companies: Akero Therapeutics, Inc.

Agios Announces Key 2025 Milestones for Innovative Rare Disease Portfolio

Read more ››

By: GlobeNewswire - 13 Jan 2025

Related companies: Agios Pharmaceuticals, Inc.

Microbix & API Ensuring Flu Tests Can Detect H5N1 Strain

Read more ››

By: GlobeNewswire - 13 Jan 2025

Related companies: Microbix Biosystems Inc. | MBX Biosciences, Inc.

Aquestive Therapeutics Provides Business Update and Outlines Key 2025 Objectives

Read more ››

By: GlobeNewswire - 13 Jan 2025

Related companies: Aquestive Therapeutics, Inc.

Foghorn Therapeutics Highlights Program Progress and Strategic Objectives for 2025

Read more ››

By: GlobeNewswire - 13 Jan 2025

Related companies: Foghorn Therapeutics, Inc.

CRISPR Therapeutics Highlights Strategic Priorities and Anticipated 2025 Milestones

Read more ››

By: GlobeNewswire - 13 Jan 2025

Related companies: CRISPR Therapeutics AG

Greenwich LifeSciences Partners with Unicancer Expanding Flamingo-01 into France

Read more ››

By: GlobeNewswire - 13 Jan 2025

Related companies: Greenwich LifeSciences, Inc.

Skye Bioscience Provides 2025 Look Ahead and Year in Review

Read more ››

By: GlobeNewswire - 13 Jan 2025

Related companies: Skye Bioscience, Inc.

Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2025 Outlook

Read more ››

By: GlobeNewswire - 13 Jan 2025

Related companies: Eledon Pharmaceuticals, Inc.

EDAP Announces Preliminary Record Fourth Quarter Focal One® System Sales and Record U.S. Procedures

Read more ››

By: GlobeNewswire - 13 Jan 2025

Related companies: EDAP TMS S.A.

Amphista Therapeutics appoints Paul Medeiros as Chief Business Officer

Read more ››

By: GlobeNewswire - 13 Jan 2025

Related companies: Amphista Therapeutics Limited

George Medicines signs exclusive licensing agreement with Bausch Health to commercialize GMRx2 in Canada, Mexico, Columbia and Central America

Read more ››

By: GlobeNewswire - 13 Jan 2025

Related companies: George Medicines

Avacta Appoints Brian Hahn as Chief Financial Officer

Read more ››

By: GlobeNewswire - 13 Jan 2025

Related companies: Avacta Group plc

ArsenalBio and Bristol Myers Squibb Achieve Milestone for AB-4000 Series as Part of Ongoing Multi-Program Collaboration to Advance Next-Generation T Cell Therapies for Solid Tumors

Read more ››

By: GlobeNewswire - 13 Jan 2025

Related companies: Arsenal Biosciences, Inc.

Cytokinetics Announces 2025 Corporate Milestones and Vision 2030

Read more ››

By: GlobeNewswire - 13 Jan 2025

Related companies: Cytokinetics, Inc.

Corvus Pharmaceuticals Announces Data from Cohort 2 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis

Read more ››

By: GlobeNewswire - 13 Jan 2025

Related companies: Corvus Pharmaceuticals, Inc.

Arbutus Provides 2025 Corporate and Financial Update

Read more ››

By: GlobeNewswire - 13 Jan 2025

Related companies: Arbutus Biopharma Corporation

New Phase IIb/III Clinical Data Demonstrates Over Three Years of Continuous Treatment with Oral Blarcamesine to Significantly Benefit Early Alzheimer’s Disease Patients

Read more ››

By: GlobeNewswire - 13 Jan 2025

Related companies: Anavex Life Sciences Corp.

Kiniksa Pharmaceuticals Reports Preliminary 2024 Net Product Revenue and Provides 2025 Net Product Revenue Guidance

Read more ››

By: GlobeNewswire - 13 Jan 2025

Related companies: Kiniksa Pharmaceuticals Corp. | Kiniksa Pharmaceuticals International, plc

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 »